Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Some patients report that injections trigger fewer gastrointestinal symptoms because the medication doesn't pass through the stomach lining the same way oral tablets do
If your skin makes too few or too many AMPs, you may have psoriasis, eczema, rosacea, or acne
As a GLP-1 receptor agonist, retatrutide may carry similar risks to semaglutide , which include: Acute pancreatitis Diabetic retinopathy complications (diabetes-related vision changes) Hypoglycemia (low blood sugar), especially when used with insulin Kidney or gallbladder issues Severe gastrointestinal reactions Allergic reactions Pulmonary aspiration during general anesthesia or deep sedation All GLP-1 receptor agonists carry a boxed warning for thyroid tumors based on animal studies
Elevated blood pressure is one of the characteristic cardiovascular risk factors often found in diabetics and prediabetics
The first injection at a new dose level often triggers a temporary return of nausea or GI symptoms
US$ 28.65
US$ 27.67
US$ 22.10
